Please try another search
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.
Name | Age | Since | Title |
---|---|---|---|
Guy Archibald Innes | 67 | 2011 | Lead Independent Director |
Alan Colman | 74 | 2011 | Chairman of Scientific Advisory Board & Independent Non Executive Director |
Edward Futcher | 69 | 2016 | Independent Non-Executive Director |
Kim Nguyen | 46 | 2021 | Independent Director |
Cameron Reynolds | 52 | 2010 | Founder, CEO, President & Director |
Martin Charles Faulkes | 79 | 2011 | Executive Chairman |
Alexander Hoffmann | - | 2023 | Member of Scientific Advisory Board |
Phillip Barnes | 62 | 2019 | Independent Non-Executive Director |
Axel Imhof | - | 2019 | Member of Scientific Advisory Board |
Mickie Henshall | 52 | 2022 | Independent Director |
Timothy Fan | - | 2022 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review